Adiponectin levels were associated with increased likelihood of metabolic health improvements and lower risk for diabetes across 6 years.

Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.

Researchers from India examined the effects of Cinnamomum zeylanicum (ceylon cinnamon) bark extracts on adiposity, insulin sensitivity and cardiometabolic markers. Their findings were published in the ...

Women with early menopause are likely to have a higher risk of heart failure, reveals a study published in the Menopause.The mechanisms through which menopausal age influences heart failure ...

The Namodenoson oral drug is well positioned in the field of anti-obesity agents due to its activity and favorable safety ...

Can-Fite BioPharma Ltd. (NYSE: CANF), shares barely budged Monday as the biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory ...

Studies indicate that lifestyle modifications can alleviate PCOS symptoms, improving insulin resistance and hormonal balance through diet and physical activity.

Adipose tissue, an active endocrine organ, secretes adipokines like leptin and adiponectin, which can either promote or inhibit cancer development when their levels are altered in obesity.

In today’s fast-paced world, maintaining a healthy lifestyle often comes with its own challenges, especially regarding weight ...

Secreted by adipose tissue, adiponectin helps regulate glucose levels and fatty acid breakdown. Higher levels of adiponectin are linked to improved insulin sensitivity and lower body weight.